BMY

$0.00

(

+0.00%

)
Quote details

stock

Bristol-Myers Squibb Company

NYSE | BMY

43.83

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 24, 2025)

$89.21B

Market Cap

17.6

P/E Ratio

2.49

EPS

$61.00

52 Week High

$42.38

52 Week Low

HEALTHCARE

Sector

BMY Chart

Recent Chart
Price Action

BMY Technicals

Tags:

BMY Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $27B
Total Revenue $48B
Cost Of Revenue $21B
Costof Goods And Services Sold $21B
Operating Income $9.7B
Selling General And Administrative $6.4B
Research And Development $9.8B
Operating Expenses $18B
Investment Income Net -
Net Interest Income -$1.9B
Interest Income $1.5B
Interest Expense $1.9B
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $9.6B
Income Before Tax -$8.4B
Income Tax Expense $554M
Interest And Debt Expense -
Net Income From Continuing Operations -$8.9B
Comprehensive Income Net Of Tax -
Ebit -$6.4B
Ebitda $3.2B
Net Income -$8.9B

Revenue & Profitability

Earnings Performance

BMY Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $93B
Total Current Assets $30B
Cash And Cash Equivalents At Carrying Value $10B
Cash And Short Term Investments $10B
Inventory $2.6B
Current Net Receivables $14B
Total Non Current Assets $63B
Property Plant Equipment $8.4B
Accumulated Depreciation Amortization Ppe -
Intangible Assets $24B
Intangible Assets Excluding Goodwill $24B
Goodwill $22B
Investments -
Long Term Investments $2.5B
Short Term Investments $513M
Other Current Assets $1.9B
Other Non Current Assets -
Total Liabilities $76B
Total Current Liabilities $24B
Current Accounts Payable $3.6B
Deferred Revenue -
Current Debt -
Short Term Debt $2.2B
Total Non Current Liabilities $52B
Capital Lease Obligations $1.6B
Long Term Debt $48B
Current Long Term Debt $2B
Long Term Debt Noncurrent -
Short Long Term Debt Total $51B
Other Current Liabilities $16B
Other Non Current Liabilities $522M
Total Shareholder Equity $16B
Treasury Stock -
Retained Earnings $15B
Common Stock $292M
Common Stock Shares Outstanding $2B

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $15B
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $9.6B
Capital Expenditures $1.2B
Change In Receivables -
Change In Inventory -$486M
Profit Loss -
Cashflow From Investment -$21B
Cashflow From Financing $5.1B
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $4.9B
Dividend Payout Common Stock $4.9B
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $0
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$8.9B

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $27B
Total Revenue $48B
Cost Of Revenue $21B
Costof Goods And Services Sold $21B
Operating Income $9.7B
Selling General And Administrative $6.4B
Research And Development $9.8B
Operating Expenses $18B
Investment Income Net -
Net Interest Income -$1.9B
Interest Income $1.5B
Interest Expense $1.9B
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $9.6B
Income Before Tax -$8.4B
Income Tax Expense $554M
Interest And Debt Expense -
Net Income From Continuing Operations -$8.9B
Comprehensive Income Net Of Tax -
Ebit -$6.4B
Ebitda $3.2B
Net Income -$8.9B

Dividends

Field Value
Ex Dividend Date 2025-10-03
Declaration Date 2025-09-17
Record Date 2025-10-03
Payment Date 2025-11-03
Amount 0.62

BMY News

BMY Profile

Bristol-Myers Squibb Company Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - GENERAL

Bristol-Myers Squibb Company (BMY) is a prominent global biopharmaceutical leader headquartered in New York City, renowned for its innovation in the discovery and delivery of transformative medicines. With a strategic focus on key therapeutic areas such as oncology, cardiovascular disease, immunology, and hematology, the company boasts a diverse portfolio that includes several well-established, market-leading therapies. BMS's dedication to addressing significant unmet medical needs, coupled with a robust development pipeline and strategic collaborations, positions it advantageously within the competitive pharmaceutical landscape. The company's ongoing commitment to advancing healthcare through cutting-edge research and development underscores its potential for sustained growth and impact in the biopharmaceutical sector.

BYND
-23.06%
$2.18
WGRX
+185.43%
$1.14
VHAI
-50.00%
$0.00
TOVX
+0.87%
$0.34
YYAI
-14.98%
$0.07
VIVK
+11.91%
$0.29
F
+12.15%
$13.84
YDKG
-15.04%
$0.06
INTC
+0.31%
$38.28
BURU
+17.26%
$0.40
CENN
-0.74%
$0.21
DVLT
+52.00%
$3.42
CGBS
-39.47%
$0.03
ASST
+27.28%
$1.10
NVDA
+2.25%
$186.26
BITF
+10.68%
$4.61
AAL
+7.90%
$13.78
TSLA
-3.39%
$433.72
DNN
+2.93%
$2.81
CJET
+27.98%
$0.11
RGTI
-1.90%
$38.84
NEUP
+54.07%
$6.24
T
+2.11%
$25.14
PLUG
+2.43%
$2.95
ADTX
-28.06%
$0.21
RIG
+0.25%
$3.90
SCNX
-39.61%
$1.57
NOK
+2.10%
$6.30
AMD
+7.63%
$252.92
AXDX
-61.36%
$0.03
ABEV
-0.90%
$2.19
QBTS
+5.11%
$32.65
GPUS
+4.19%
$0.40
RF
+1.95%
$24.57
CAN
+7.38%
$1.89
LAES
+22.55%
$7.01
SOFI
+3.31%
$29.01
QLGN
+3.11%
$3.64
NEHC
+48.35%
$5.86
NUAI
+48.35%
$5.86
ONDS
+5.66%
$7.46
GRAB
+2.27%
$5.85
TLRY
+0.67%
$1.49
QS
+14.73%
$16.82
ADAP
-7.57%
$0.06
SNAP
+1.01%
$7.95
CIFR
+19.73%
$20.66
WTO
-7.14%
$0.06
AIRE
-22.42%
$0.76
ETHD
-3.40%
$3.83
JOBY
+2.93%
$16.13
ACHR
+3.48%
$11.29
IONZ
-4.02%
$3.82
RMBL
+60.50%
$3.21
BAC
+1.56%
$52.57
RXRX
+5.41%
$6.04
AMZN
+1.41%
$224.21
AAPL
+1.24%
$262.82
ADD
-25.47%
$0.05
NIO
+0.14%
$6.90
QUBT
-2.57%
$15.53
IREN
+12.60%
$62.90
RR
+12.17%
$6.08
BTBT
+5.10%
$3.91
AMC
-1.46%
$2.69
SRM
+53.27%
$10.30
NVTS
+3.37%
$14.07
PLTR
+2.29%
$184.63
CLOV
+19.37%
$3.82
UUUU
+0.47%
$21.36
BTG
-0.38%
$5.21
DFLI
+13.27%
$1.28
RVPH
+18.99%
$0.67
BBD
+0.14%
$3.35
MARA
+1.66%
$19.54
CUTR
-10.19%
$0.09
APLD
+0.14%
$33.43
PBR
-0.84%
$11.74
KDLY
+5.66%
$0.84
NAKA
+5.66%
$0.84
WU
+10.19%
$8.97
GOOGL
+2.70%
$259.92
WLGS
-5.57%
$0.04
RIVN
-0.84%
$12.98
SOUN
-1.42%
$17.98
PFE
+0.36%
$24.76
IONQ
+1.56%
$60.30
WULF
+6.44%
$13.71
VZ
+1.09%
$38.82
ETWO
0.00%
$3.30
RGTZ
+3.08%
$15.36
LAZR
+31.36%
$2.22
SKYQ
+9.15%
$0.50
MU
+5.95%
$219.02
JBLU
0.00%
$4.57
SMCI
+0.77%
$48.29
CLSK
+9.59%
$19.36
WBD
-0.47%
$21.15
HOOD
+4.06%
$139.79
LUMN
+3.78%
$8.08
BYND
-23.06%
$2.18
WGRX
+185.43%
$1.14
VHAI
-50.00%
$0.00
TOVX
+0.87%
$0.34
YYAI
-14.98%
$0.07
VIVK
+11.91%
$0.29
F
+12.15%
$13.84
YDKG
-15.04%
$0.06
INTC
+0.31%
$38.28
BURU
+17.26%
$0.40
CENN
-0.74%
$0.21
DVLT
+52.00%
$3.42
CGBS
-39.47%
$0.03
ASST
+27.28%
$1.10
NVDA
+2.25%
$186.26
BITF
+10.68%
$4.61
AAL
+7.90%
$13.78
TSLA
-3.39%
$433.72
DNN
+2.93%
$2.81
CJET
+27.98%
$0.11
RGTI
-1.90%
$38.84
NEUP
+54.07%
$6.24
T
+2.11%
$25.14
PLUG
+2.43%
$2.95
ADTX
-28.06%
$0.21
RIG
+0.25%
$3.90
SCNX
-39.61%
$1.57
NOK
+2.10%
$6.30
AMD
+7.63%
$252.92
AXDX
-61.36%
$0.03
ABEV
-0.90%
$2.19
QBTS
+5.11%
$32.65
GPUS
+4.19%
$0.40
RF
+1.95%
$24.57
CAN
+7.38%
$1.89
LAES
+22.55%
$7.01
SOFI
+3.31%
$29.01
QLGN
+3.11%
$3.64
NEHC
+48.35%
$5.86
NUAI
+48.35%
$5.86
ONDS
+5.66%
$7.46
GRAB
+2.27%
$5.85
TLRY
+0.67%
$1.49
QS
+14.73%
$16.82
ADAP
-7.57%
$0.06
SNAP
+1.01%
$7.95
CIFR
+19.73%
$20.66
WTO
-7.14%
$0.06
AIRE
-22.42%
$0.76
ETHD
-3.40%
$3.83
JOBY
+2.93%
$16.13
ACHR
+3.48%
$11.29
IONZ
-4.02%
$3.82
RMBL
+60.50%
$3.21
BAC
+1.56%
$52.57
RXRX
+5.41%
$6.04
AMZN
+1.41%
$224.21
AAPL
+1.24%
$262.82
ADD
-25.47%
$0.05
NIO
+0.14%
$6.90
QUBT
-2.57%
$15.53
IREN
+12.60%
$62.90
RR
+12.17%
$6.08
BTBT
+5.10%
$3.91
AMC
-1.46%
$2.69
SRM
+53.27%
$10.30
NVTS
+3.37%
$14.07
PLTR
+2.29%
$184.63
CLOV
+19.37%
$3.82
UUUU
+0.47%
$21.36
BTG
-0.38%
$5.21
DFLI
+13.27%
$1.28
RVPH
+18.99%
$0.67
BBD
+0.14%
$3.35
MARA
+1.66%
$19.54
CUTR
-10.19%
$0.09
APLD
+0.14%
$33.43
PBR
-0.84%
$11.74
KDLY
+5.66%
$0.84
NAKA
+5.66%
$0.84
WU
+10.19%
$8.97
GOOGL
+2.70%
$259.92
WLGS
-5.57%
$0.04
RIVN
-0.84%
$12.98
SOUN
-1.42%
$17.98
PFE
+0.36%
$24.76
IONQ
+1.56%
$60.30
WULF
+6.44%
$13.71
VZ
+1.09%
$38.82
ETWO
0.00%
$3.30
RGTZ
+3.08%
$15.36
LAZR
+31.36%
$2.22
SKYQ
+9.15%
$0.50
MU
+5.95%
$219.02
JBLU
0.00%
$4.57
SMCI
+0.77%
$48.29
CLSK
+9.59%
$19.36
WBD
-0.47%
$21.15
HOOD
+4.06%
$139.79
LUMN
+3.78%
$8.08

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.